Protandim®, a patented product developed by LifeVantage Corporation (OTCBB:LFVN), was proven by an earlier study to actually slow the progressive rate of aging. This new study confirms that Protandim's® gene induction approach to antioxidant therapy provides much broader and more powerful benefits to the body than those provided by vitamins such as E and C, according to the Company.
Results of a new peer-reviewed study published online in the journal Free Radical Biology and Medicine clearly demonstrates that the synergistic impact of the active ingredients used in the formulation of Protandim® dramatically increases the body's production of glutathione, a key antioxidant and anti-aging factor, as well as increases important antioxidant enzymes.
